Presentation is loading. Please wait.

Presentation is loading. Please wait.

Prostaglandin E2 suppresses CCL27 production through EP2 and EP3 receptors in human keratinocytes  Naoko Kanda, MD, PhD, Hiroshi Mitsui, MD, PhD, Shinichi.

Similar presentations


Presentation on theme: "Prostaglandin E2 suppresses CCL27 production through EP2 and EP3 receptors in human keratinocytes  Naoko Kanda, MD, PhD, Hiroshi Mitsui, MD, PhD, Shinichi."— Presentation transcript:

1 Prostaglandin E2 suppresses CCL27 production through EP2 and EP3 receptors in human keratinocytes 
Naoko Kanda, MD, PhD, Hiroshi Mitsui, MD, PhD, Shinichi Watanabe, MD, PhD  Journal of Allergy and Clinical Immunology  Volume 114, Issue 6, Pages (December 2004) DOI: /j.jaci Copyright © 2004 American Academy of Allergy, Asthma and Immunology Terms and Conditions

2 Fig 1 Flow cytometric analysis of EP1, EP2, EP3, and EP4 expression on keratinocytes. ∗P < .05 versus EP1; †P < .05 versus EP4. MFI, Mean fluorescence intensity. Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci ) Copyright © 2004 American Academy of Allergy, Asthma and Immunology Terms and Conditions

3 Fig 2 Inhibition by NF-κB–induced antisense oligonucleotides on TNF-α–induced CCL27 secretion (A), mRNA expression (B), and NF-κB transcriptional activity (C). ∗P < .05 versus control cells; †P < .05 versus TNF-α alone. AS, Antisense oligonucleotide; con, control; luc, luciferase. Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci ) Copyright © 2004 American Academy of Allergy, Asthma and Immunology Terms and Conditions

4 Fig 3 Inhibition by PGE2 or EP agonists on TNF-α–induced CCL27 secretion (A), mRNA expression (B), and NF-κB transcriptional activity (C). CCL27 secretion in control cells was 0.21 ± 0.03 ng/106 cells. Fig 3, A: ∗P < .05 versus TNF-α alone. Fig 3, B and C: ∗P < .05 versus control cells; †P < 0.05 versus TNF-α alone. Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci ) Copyright © 2004 American Academy of Allergy, Asthma and Immunology Terms and Conditions

5 Fig 4 Blocking effects of EP antagonists on PGE2-induced inhibition of CCL27 secretion (A) and NF-κB transcriptional activity (B). ∗P < .05 versus control cells; †P < .05 versus TNF-α alone; ‡P < .05 versus TNF-α plus PGE2. Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci ) Copyright © 2004 American Academy of Allergy, Asthma and Immunology Terms and Conditions

6 Fig 5 A, PGE2-induced increase of intracellular Ca2+ concentration. B, Blocking effects of TMB-8 or U73122 on PGE2-induced inhibition of CCL27 secretion or NF-κB activity. ∗P < .05 versus control cells; †P < .05 versus TNF-α alone; ‡P < .05 versus TNF-α plus PGE2. SK&F, SK&F96365; luc, luciferase. Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci ) Copyright © 2004 American Academy of Allergy, Asthma and Immunology Terms and Conditions

7 Fig 6 Maximal increase of intracellular Ca2+ concentration (A) and increase of intracellular cAMP level (B) by PGE2 or EP agonists (each 10 μmol/L). ∗P < .05 versus control cells. Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci ) Copyright © 2004 American Academy of Allergy, Asthma and Immunology Terms and Conditions


Download ppt "Prostaglandin E2 suppresses CCL27 production through EP2 and EP3 receptors in human keratinocytes  Naoko Kanda, MD, PhD, Hiroshi Mitsui, MD, PhD, Shinichi."

Similar presentations


Ads by Google